Correlation Between Achilles Therapeutics and Quoin Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Achilles Therapeutics and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Quoin Pharmaceuticals.

Diversification Opportunities for Achilles Therapeutics and Quoin Pharmaceuticals

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Achilles and Quoin is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Quoin Pharmaceuticals go up and down completely randomly.

Pair Corralation between Achilles Therapeutics and Quoin Pharmaceuticals

Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 0.43 times more return on investment than Quoin Pharmaceuticals. However, Achilles Therapeutics PLC is 2.35 times less risky than Quoin Pharmaceuticals. It trades about 0.15 of its potential returns per unit of risk. Quoin Pharmaceuticals Ltd is currently generating about 0.05 per unit of risk. If you would invest  74.00  in Achilles Therapeutics PLC on August 29, 2024 and sell it today you would earn a total of  33.00  from holding Achilles Therapeutics PLC or generate 44.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Achilles Therapeutics PLC  vs.  Quoin Pharmaceuticals Ltd

 Performance 
       Timeline  
Achilles Therapeutics PLC 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Achilles Therapeutics PLC are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical indicators, Achilles Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.
Quoin Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Quoin Pharmaceuticals Ltd are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Quoin Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Achilles Therapeutics and Quoin Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Achilles Therapeutics and Quoin Pharmaceuticals

The main advantage of trading using opposite Achilles Therapeutics and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.
The idea behind Achilles Therapeutics PLC and Quoin Pharmaceuticals Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance